eISSN: 3134-8785 / ISSN: 3134-8777
Register
Login
Bangaldesh Journal of Cardivascular Intervention
2025, Volume 3, Issue 2 : 15-18
Research Article
Role of Coronary Revascularization in Heart Failure Outcomes
 ,
 ,
 ,
1
Department of Cardiology, Global Heart Institute, Boston, USA
2
Division of Interventional Cardiology, University Medical Center, London, UK
3
Department of Heart Failure and Transplant Cardiology, National Heart Centre, Dubai, UAE
4
Department of Clinical Research, International Cardiovascular Sciences Institute, Sydney, Australia
Abstract

Background: Coronary artery disease is a major cause of heart failure, especially heart failure with reduced ejection fraction. Coronary revascularization may improve symptoms, ventricular function, hospitalization rates, and survival in selected patients.

Objective: To evaluate the role of coronary revascularization in improving clinical outcomes among patients with ischemic heart failure.

Methods: A prospective multicenter observational study included 680 patients with heart failure and significant coronary artery disease undergoing medical therapy, PCI, or CABG between January 2020 and December 2024. Outcomes included mortality, heart failure hospitalization, left ventricular ejection fraction improvement, functional status, and major adverse cardiovascular events.

Results: Revascularized patients showed greater improvement in angina, functional capacity, and left ventricular ejection fraction compared with medical therapy alone. CABG demonstrated stronger long-term survival benefit in patients with multivessel disease and severe LV dysfunction, while PCI was associated with faster symptom relief and lower early procedural burden.

Conclusion: Coronary revascularization plays an important role in selected patients with ischemic heart failure. Optimal benefit depends on coronary anatomy, myocardial viability, LV function, comorbidity burden, and Heart Team decision-making.

 

Keywords
License
Copyright (c) Bangaldesh Journal of Cardivascular Intervention
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Bangladesh J. Cardiovasc. Intvn. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
1-3
Long-Term Outcomes of Multivessel PCI in Acute Coronary Syndrome: A Systematic Review of Clinical Effectiveness, Safety, and Prognostic Implications
1-8
Role of High-Sensitivity Troponin in Guiding Early Coronary Intervention: Diagnostic Accuracy, Risk Stratification, and Clinical Outcomes in Acute Coronary Syndromes
1-4
Hybrid Revascularization Strategies in Complex Coronary Artery Disease (CAD): Integrating Surgical and Percutaneous Approaches for Optimal Outcomes
1-5
Bangaldesh Journal of Cardivascular Intervention
+447460013985
support@bd-jci.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©Bangaldesh Journal of Cardivascular Medicine. All rights reserved.
|
|
|